Page 2 of 9
By initialing I, the Parent/Managing Conservator/Guardian, am indicating that I have read understand the information included on this
page. Parent’s Initials ______
Oklahoma State Department of Health 11/2013
Health Care Information
with their adrenal glands (chronic adrenal failure), or who take medicine to thin their blood or take certain
steroid medicines should not have a non-surgical abortion. You should discuss with your physician whether
you have any medical conditions that would make a medical abortion unsafe for you.
Minor’s Initials __________
Please review the applicable description of the procedure and the associated risks and hazards planned for the minor
(Minor should initial the applicable procedure):
Medical (Nonsurgical) Abortion
Medical abortion is a way to end a pregnancy by using an abortion inducing drug as an alternative to surgical
procedures. The Food and Drug Administration allows this type of abortion up to 49 days (7 weeks) after the last
menstrual period. The gestational age must be determined before a physician can administer these drugs to a
pregnant woman.
The physician administering the medicines (such as Mifepristone RU 486) for medical termination of early
pregnancy must be able to provide surgical intervention or have made plans for provision of such care through
other qualified physicians, and be able to assure patient access to medical facilities equipped to provide blood
transfusions and resuscitation, if necessary.
Methods of Non-surgical Abortion
Oklahoma law (Title 63 O.S. §1-729a) states that the physician administering any abortion inducing drug must be
able to determine the duration of the pregnancy accurately, be able to diagnose ectopic pregnancies, be able to
provide surgical intervention or have made plans for provision of such care through other qualified physicians,
and be able to assure patient access to medical facilities equipped to provide blood transfusions and
resuscitation, if necessary. The physician administering Mifepristone (RU 486) is required to fully explain the
procedure to the patient including whether the physician is using the drug in accordance with the U.S. Food and
Drug Administration tested and authorized protocol. If the physician is using an evidence-based regimen, the
physician must provide detailed information on the regimen being used. In addition, the physician who is
prescribing, dispensing, or otherwise providing an abortion inducing drug must be physically present in the same
room as the patient when the drug or chemical is first provided to the patient (Title 63 O.S. §1-729.1)
Mifepristone (RU 486), Misoprostol, and Methotrexate are drugs used in regimens for medical termination of
early pregnancies. These drugs are given by mouth or placed in the woman’s vagina. These drugs cause abortion
by causing the uterus to contract and expel the fetus and placenta.
After receiving these drugs, you might experience cramping and bleeding, pass clots, tissue, and the unborn
child within hours or days. Some amount of bleeding is common following a medical abortion.
Your doctor will tell you when you need to return to be checked. If you are still pregnant at that visit, you will be
given a second drug either by mouth or vaginally. You will be instructed when to return for an important follow-
up visit. Your doctor will determine whether your pregnancy has completely ended. If you are still pregnant, a
surgical procedure could be necessary.